HBV reactivation under immunosuppressive treatment – a case series

BMC Infectious Diseases

Oral Presentation

Aida Adamescu¹  Smaranda Gliga²  Daniela Munteanu²  Alina Lobodan²  Violeta Molagic²  Raluca Mihăilescu²  Anca-Ruxandra Negru²  Georgiana Jugănaru²  Irina Lăpădat²  Mihaela Rădulescu³  Cristina Popescu³  Cătălin Tilişcan³  Victoria Aramă³ 

[1] Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;National Institute for Infectious Diseases "Prof. Dr. Matei Balş", Bucharest, Romania;National Institute for Infectious Diseases "Prof. Dr. Matei Balş", Bucharest, Romania;Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;

关键词: Lamivudine;    Acute Liver Failure;    Immunosuppressive Treatment;    Entecavir;    Rheumatologic Disease;   

DOI  :  10.1186/1471-2334-14-S7-O11

来源: Springer

【 授权许可】

Unknown   
© Rădulescu et al; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.